Skip to main content

Peer Review reports

From: Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial

Original Submission
16 Feb 2020 Submitted Original manuscript
20 Mar 2020 Reviewed Reviewer Report
23 Mar 2020 Reviewed Reviewer Report
21 Apr 2020 Author responded Author comments - Nobuyoshi Hamao
25 Apr 2020 Reviewed Reviewer Report
8 May 2020 Author responded Author comments - Nobuyoshi Hamao
Resubmission - Version 2
21 Apr 2020 Submitted Manuscript version 2
15 May 2020 Author responded Author comments - Nobuyoshi Hamao
Resubmission - Version 3
15 May 2020 Submitted Manuscript version 3
20 May 2020 Author responded Author comments - Nobuyoshi Hamao
Resubmission - Version 4
20 May 2020 Submitted Manuscript version 4
Publishing
22 May 2020 Editorially accepted
5 Jun 2020 Article published 10.1186/s12890-020-01198-4

You can find further information about peer review here.

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us